Healthtech Startups

A digital health resource platform providing medical professionals with educational information and clinical resources about transthyretin amyloid cardiomyopathy (ATTR-CM) and related cardiac and neurological conditions.

4 investors

Eleanor Health is an outpatient addiction treatment program that delivers remote evidence-based care for substance use disorder, including medication-assisted treatment and counseling. The service addresses underlying trauma and behavioral health conditions alongside addiction through online consultations with addiction counselors and peer recovery specialists.

4 investors

ElevateBio is a contract development and manufacturing organization (CDMO) for advanced therapies, offering discovery, process development, analytics, manufacturing, and regulatory support for cell therapies, viral vectors, mRNA therapeutics, and gene editing. It partners with drug developers to bring cell and gene therapies from early discovery through commercial-scale cGMP manufacturing.

4 investors

Elfie is a free health app that rewards users with coins for self-monitoring activities such as tracking vitals, walking, and managing medication, which can be redeemed for vouchers, discounts, and donations. It targets patients with chronic conditions like hypertension, diabetes, and obesity, and offers cost-control features for payers and employers.

4 investors

Ember AI provides an AI-powered platform that automates healthcare billing and prior authorization processes to prevent coverage denials. The platform continuously tracks payment policies and payor behavior to help healthcare providers streamline their revenue cycle operations.

4 investors

Emboline develops the Emboliner Embolic Protection System, a cerebral protection device aimed at preventing stroke during transcatheter aortic valve replacement (TAVR) procedures. The company serves interventional cardiologists in the structural heart and cardiovascular medical device market.

4 investors

Emitrr provides an AI-powered answering service that automatically handles inbound patient calls for healthcare practices, capturing caller details and routing urgent requests to staff. The service answers calls instantly during peak hours, after-hours, or staffing shortages, reducing voicemail backlogs and front desk workload.

4 investors

Scene Health (formerly emocha) runs a video Directly Observed Therapy (DOT) program that uses asynchronous video and a multilingual app, paired with a high-touch care team, to monitor and improve medication adherence for patients with chronic conditions. It serves health plans, public health departments, pharmaceutical sponsors, CROs, and clinical trial sites to improve clinical outcomes, reduce costs, and track real-time adherence data.

4 investors

Empatica offers an FDA-cleared health monitoring platform combining medical wearables and digital biomarkers to collect continuous, clinical-quality health data from daily life. It serves researchers, clinicians, and pharmaceutical companies for clinical trials and remote patient monitoring across therapeutic areas including neurology and Parkinson's disease.

4 investors

ENA Respiratory develops and brings respiratory treatments to market across the US and other regions. The company operates at the intersection of pharmaceutical product development and clinical innovation, with deep expertise in bringing early-stage respiratory therapies through development and regulatory approval.

4 investors

Enable Injections develops and manufactures enFuse, a wearable drug delivery device that delivers large volumes of pharmaceutical and biologic therapeutics subcutaneously for patients with chronic diseases. The company serves healthcare providers, payers, and patients by offering a mechanical hands-free alternative to intravenous treatment.

4 investors

Encora Therapeutics makes the Encora X1, an FDA-cleared, prescription wrist-worn device that uses mechanical neurostimulation to relieve hand tremors in adults with essential tremor. The device is designed as a non-drug option that can be used alone or alongside existing treatment plans.

4 investors

Endomag makes the Magseed marker, a magnetic seed used to localize breast cancer lesions before and during surgery as an alternative to guidewire localization. It serves surgeons and radiologists treating breast cancer patients in the medical device field.

4 investors

Endomedix develops polysaccharide-based biomaterials and medical technology, with a pipeline moving from polysaccharide chemistry toward preclinical testing and clinical trials. The company works with a small internal R&D team supported by external scientific consultants.

4 investors

Endpoint Health develops immunology-focused therapeutics paired with diagnostic tests designed to match individual patients with treatments suited to their biology for critical and chronic illnesses.

4 investors

Enliven Therapeutics is a clinical-stage biopharmaceutical company that discovers and develops small molecule therapeutics using a precision medicine approach, with a focus on oncology and hematology. Its discovery work combines clinically validated biological targets with differentiated chemistry to develop drugs for unmet medical needs.

4 investors

ENTER provides healthcare payment solutions that help medical providers accelerate revenue collection and increase earnings through revenue cycle management and patient collections services.

4 investors

Envoy America provides transportation and care coordination services for patients, older adults, and individuals with disabilities through partnerships with healthcare systems and senior living communities. The company combines compassionate service with technology to improve health outcomes and quality of life.

4 investors

Epinoma develops EpiAmp, a methyl-preserving amplification technology to analyze epigenetic changes and methylation patterns for applications in disease detection, drug development, and patient stratification. The company serves research institutions, pharmaceutical companies, and clinical diagnostic organizations in the biotech and healthcare sectors.

4 investors

Eternatear develops diagnostic and therapeutic products for dry eye disease, particularly targeting Meibomian Gland Dysfunction. The company is founded by experienced ophthalmology and medical device leaders with extensive track records in bringing dry eye treatments to market.

4 investors

Evergreen Nephrology partners with nephrologists to manage kidney care for patients with kidney disease, focusing on outcomes such as preventing hospitalizations, slowing disease progression, and increasing transplant rates. It operates a value-based kidney care model that supports physicians in coordinating care for their kidney patient populations.

4 investors

Marathon Health provides advanced primary care combined with lifestyle and chronic condition management for employers and health plans, using health coaches and registered dietitians alongside providers. It delivers services through onsite, nearsite, and network health centers as well as virtual care across the US, covering areas like GLP-1 support, diabetes, hypertension, and cardiometabolic risk management.

4 investors

Evidium provides predictive analytics and clinical progression modeling for self-insured health plans and employers, forecasting disease evolution and high-cost claim exposure to improve stop-loss underwriting and financial planning. The platform serves plan sponsors, health plans, and other stakeholders in the self-insured benefits ecosystem by converting medical knowledge into actionable insights for managing health plan risk.

4 investors

evolvedMD integrates behavioral health services into primary care settings to improve access to mental health treatment. The company serves primary care practices and their patients seeking integrated care for depression, anxiety, and other mental health conditions.

4 investors